LBPWQ (4d pharma) Accounts Payable: $1.62 Mil (As of Dec. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LBPWQ 4d pharma PLC LBPWQ
34 GF Score
Price $0.00
! 9 Warning Signs
View Full Analysis

What is 4d pharma Accounts Payable?

4d pharma LBPWQ 34 Accounts Payable is $1.62 Mil as of Dec. 2021. GuruFocus rates LBPWQ with a GF Score™ of 34/100. The stock has 9 warning signs investors should review.

4d pharma's Accounts Payable for the quarter that ended in Dec. 2021 was $1.62 Mil.

4d pharma's quarterly Accounts Payable increased from Dec. 2020 ($4.44 Mil) to Jun. 2021 ($9.76 Mil) but then declined from Jun. 2021 ($9.76 Mil) to Dec. 2021 ($1.62 Mil).

4d pharma's annual Accounts Payable increased from Dec. 2019 ($1.64 Mil) to Dec. 2020 ($4.44 Mil) but then declined from Dec. 2020 ($4.44 Mil) to Dec. 2021 ($1.62 Mil).

4d pharma Accounts Payable Historical Data

* Premium members only.

The historical data trend for 4d pharma's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4d pharma Accounts Payable Chart

4d pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Accounts Payable
Get a 7-Day Free Trial 2.42 2.44 1.64 4.44 1.62

4d pharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.64 8.04 4.44 9.76 1.62
LBPWQ
34GF Score
4d pharma PLC LBPWQ
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4d pharma Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $1.62 Mil mean?
4d pharma (LBPWQ) has a Accounts Payable of $1.62 Mil as of Dec. 2021. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on 4d pharma and its competitors.
Is 4d pharma's Accounts Payable too high?
4d pharma's current Accounts Payable is $1.62 Mil. Overall, 4d pharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does 4d pharma's Accounts Payable compare to REGN and VRTX?
4d pharma's Accounts Payable of $1.62 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on 4d pharma and its competitors. 4d pharma's current Accounts Payable is $1.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4d pharma stock overvalued right now?
4d pharma (LBPWQ) has a current Accounts Payable of $1.62 Mil. The current Accounts Payable is $1.62 Mil. 4d pharma's overall GF Score™ is 34/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For 4d pharma (LBPWQ), the current Accounts Payable is $1.62 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

4d pharma Business Description

Address 9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.
34GF Score

Get the complete analysis for LBPWQ

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price